In 2022, there were around 0.25 cases of West Nile virus per 100,000 population in the United States. This statistic shows the rate of cases of West Nile virus and other arboviral diseases in the U.S. in 2022.

In 2022, there were around 862 hospitalizations and 93 deaths due to West Nile virus in the United States. This statistic shows the number of cases of West Nile virus and other arboviral diseases in the U.S. in 2022, by outcome.

In 2022, there were approximately 429 cases of West Nile virus in the United States among people aged 18 to 59 years. The majority of cases, however, were reported in individuals aged 60 and older, with 678 cases documented in this age group. This statistic shows the number of cases of West Nile virus and other arboviral diseases in the U.S. in 2022, by age.

In 2022, there were around 827 cases of West Nile virus and 43 cases of Powassan in the United States. This statistic shows the number of cases of West Nile virus and other arboviral diseases in the U.S. in 2022.

This graph shows the total number of mosquito-borne disease cases reported in the U.S. from 2004 to 2018. In the year 2004, there were 4,858 reported mosquito-borne disease cases, while there were 5,847 such cases in 2018.

The deadliest animals in the world based on the number of human deaths per year is not a creature that humans usually find scary, such as a lion or snake. Mosquitos are by far the deadliest creature in the world when it comes to annual human deaths, causing around one million deaths per year, compared to 100,000 deaths from snakes and 250 from lions. Perhaps surpringly, dogs are the third deadliest animal to humans. Dogs are responsible for around 30,000 human deaths per year, with the vast majority of these deaths resulting from rabies that is transmitted from the dog. Malaria
Mosquitos are the deadliest creature in the world because they transmit a number of deadly diseases, the worst of which is malaria. Malaria is a mosquito-borne disease caused by a parasite that results in fever, chills, headache, vomiting and, if left untreated, death. Malaria disproportionately affects poorer regions of the world such as Africa and South-East Asia. In 2020, there were around 627,000 deaths from malaria worldwide. Mosquito-borne diseases in the U.S.
The most common mosquito-borne diseases reported in the United States include West Nile virus, malaria, and dengue viruses. Many of these cases, however, are from travelers who contracted the disease in another country - this is especially true for malaria, Zika, and dengue. In 2018, the states of California, New York, and Texas reported the highest number of mosquito-borne disease cases in the United States.

This graph shows the total number of mosquito-borne disease cases reported in the U.S. in 2018, by state. In that period, in the state of California, 521cases of mosquito-borne disease were reported. In total, there were ***** mosquito-borne disease cases that year.

In 2021, there were around 16,211 confirmed cases of Lyme disease, making it the most common vector-borne disease in the United States. Lyme disease is transmitted to humans through ticks. The most common mosquito-borne disease in the U.S. at that time was West Nile virus. This statistic displays the number of cases of notifiable vector-borne diseases in the U.S. in 2021, by disease. Vector-borne disease Vector-borne diseases are infectious human illnesses caused by parasites, viruses, or bacteria, and are transmitted through other living organisms called vectors, either between humans or from animal to human. Common vectors include mosquitoes, ticks, and various types of flies. Mosquitoes cause the highest number of human deaths annually worldwide, as they transmit diseases such as malaria, West Nile virus, and Dengue. Lyme disease In the United States, the highest number of confirmed cases of Lyme disease in 2022 was reported in New York. After a bite from an infected tick, if left untreated, the infection can spread through different body systems, causing a variety of potentially debilitating and chronic symptoms. When signs of the disease, such as EM rash, fever, and fatigue are recognized early on, antibiotics can combat the spread of the infection to complete recovery.

Body Worn Insect Repellents Market Outlook

The global body worn insect repellents market size was valued at approximately USD 800 million in 2023 and is projected to reach around USD 1.5 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7%. The market's robust growth trajectory is primarily driven by increasing awareness about vector-borne diseases and a rising inclination towards outdoor recreational activities. Heightened consumer focus on health and safety, coupled with the proliferation of innovative insect repellent products, has significantly bolstered market growth.

One of the major growth factors in the body worn insect repellents market is the increasing prevalence of vector-borne diseases such as malaria, dengue, and Zika virus. According to the World Health Organization, vector-borne diseases account for more than 17% of all infectious diseases, causing over 700,000 deaths annually. This alarming statistic has led to a surge in demand for effective insect repellents, especially in tropical and subtropical regions where these diseases are endemic. The efficacy of body worn insect repellents in providing prolonged protection has made them a preferred choice among consumers, further driving market expansion.

The trend towards outdoor and adventure tourism is another crucial driver for the body worn insect repellents market. Adventure tourism, including activities such as camping, hiking, and fishing, exposes individuals to various insect bites, necessitating the use of reliable repellent products. Additionally, the increase in outdoor and sports activities among children has amplified the demand for child-friendly insect repellents. This shift in consumer behavior towards outdoor experiences is anticipated to boost the market over the forecast period significantly.

Technological advancements and product innovations are also playing a pivotal role in the growth of the body worn insect repellents market. Companies are investing in research and development to create new formulations and delivery systems that enhance the effectiveness and convenience of insect repellents. For instance, the development of long-lasting insect repellent patches and wristbands has garnered significant consumer interest. Moreover, the incorporation of natural ingredients like essential oils is gaining traction among health-conscious consumers, which is expected to create new growth opportunities within the market.

Regional outlook reveals that North America and Asia Pacific are the most promising markets for body worn insect repellents. North America, led by the United States, is witnessing an increased adoption of insect repellents due to the rising cases of Lyme disease and West Nile virus. Meanwhile, Asia Pacific, with its high incidence of mosquito-borne diseases and large population base, is experiencing substantial market growth. Countries such as India, China, and Indonesia are major contributors to this regional demand, driven by government initiatives and increasing consumer awareness.

Product Type Analysis

The body worn insect repellents market is segmented by product types into insect repellent clothing, insect repellent wristbands, insect repellent patches, and others. Insect repellent clothing is designed to provide protection against insect bites through fabric treated with insect-repellent chemicals. This segment is gaining popularity due to its dual functionality of regular clothing and bug protection. The convenience of not having to apply lotion or spray makes it a preferred choice for many, especially for outdoor enthusiasts and travelers.

Insect repellent wristbands are another innovative product type that has seen significant acceptance, especially among children and young adults. These wristbands are infused with repellents such as citronella or other essential oils, offering a wearable and non-messy solution for insect protection. The ease of use and fashionable designs have made them popular among consumers, contributing to their growing market share. Additionally, the use of non-toxic and hypoallergenic materials in these wristbands appeals to health-conscious consumers.

Insect repellent patches are gaining traction due to their ease of application and long-lasting effects. These patches are typically infused with DEET or natural repellents and can be applied directly to clothing or skin. They provide consistent pro

Snapshot img

Quinidine Sulfate Market Size 2024-2028

The quinidine sulfate market size is forecast to increase by USD 272.6 million at a CAGR of 4.5% between 2023 and 2028.

The market is experiencing significant growth due to the rising incidence of malaria, a mosquito-borne disease, worldwide. Malaria remains a major public health concern, particularly in tropical and subtropical regions. The disease causes a significant number of deaths each year, making it essential to develop effective treatments. Furthermore, strong funding for malaria eradication initiatives, including the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the World Health Organization, is driving market growth. Additionally, the emergence of insecticide-resistant vectors is posing a significant challenge to the market, as current treatments may become less effective. Further, this trend is driving the demand for medical technology advancements, such as malaria rapid diagnostic devices, which offer quick test results and aid in diagnosis. To address this issue, researchers are exploring new treatments, such as Quinidine Sulfate, which can help combat resistance and improve patient outcomes.

What will be the Size of the Quinidine Sulfate Market During the Forecast Period?

Request Free Sample

The market encompasses the production, distribution, and consumption of this pharmaceutical component used primarily in the treatment of various cardiovascular and malarial conditions. With the increasing global burden of communicable diseases such as malaria and the rising prevalence of cardiovascular diseases (CVD), the demand is expected to grow. Malaria, a parasitic disease, is a significant cause of morbidity and mortality worldwide, leading to a high demand for malaria diagnostic and treatment methods.



Quinidine sulfate is administered intravenously and orally to manage atrial and ventricular arrhythmias, heart rates in cardiac care, and structural heart diseases. Additionally, its use extends to pediatrics and adults with hypertension, smoking population, and alcoholism culture. The incidence of arrhythmia and atrial fibrillation In the adult population further fuels the market growth. As an antiarrhythmic, quinidine sulfate plays a crucial role in cardiac care, home care, clinics, and hospitals.

How is this Quinidine Sulfate Industry segmented and which is the largest segment?

The industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Disease Type

  Malaria
  Arrhythmias


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  Asia

    China


  Rest of World (ROW)

By Disease Type Insights

The malaria segment is estimated to witness significant growth during the forecast period.

Quinidine sulfate is a crucial medication In the healthcare industry, primarily used for treating malaria, particularly severe or complicated cases caused by Plasmodium falciparum. As an antimalarial drug, it inhibits the parasite's ability to metabolize heme, a vital component for its survival. In cardiovascular medicine, quinidine sulfate functions as an antiarrhythmic agent for managing atrial and ventricular arrhythmias in adults and geriatric populations. The incidence of arrhythmias is higher among individuals with structural heart diseases, smoking population, alcoholism culture, and cardiovascular genetic disorders. This is administered through intravenous and oral methods. In the US, cardiac care units, hospitals, clinics, and healthcare professionals, including cardiologists and general practitioners, hospital pharmacies, retail pharmacies, and internet pharmacies, stock and dispense this medication.

Malaria treatment poses health risks, including gastrointestinal issues and cinchonism. Regulatory restrictions and pharmacological side effects are essential considerations for its use. The market is influenced by the incidence of malaria cases, the prevalence of cardiovascular diseases, and the demand for novel formulations and drug delivery technologies in individualized medicine.

Get a glance at the Industry report of share of various segments Request Free Sample

The malaria segment was valued at USD 636.10 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

Asia is estimated to contribute 44% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

Quinidine sulfate is a crucial therapeutic agent used primarily In the treatment of malaria and certain cardiovascular conditions, such as arrhy

Mosquito pool detections of St. Louis encephalitis virus (SLEV) and West Nile virus (WNV) in California counties where SLEV was detected, 2015–2020. Number of positive Culex spp. pools (Mosquito Infection Rate per 1,000 tested).

Number of human St. Louis encephalitis virus (SLEV) cases and cumulative incidence of SLEV disease cases by year, California, 2016–2020.–Indicates no detections.

The fittings are displayed in Figure 4.Best fit parameter values to the Culex pipiens complex surveillance data.

In 2023, Mexico reported 29 cases of the Zika virus disease, up from 12 cases recorded a year earlier. During the period analyzed, 2016 was the year with the highest number of Zika infections in the North American country, with more than 8,000 cases. Within the Latin American and Caribbean region, Brazil was the country that accounted for most Zika cases that year. A vector borne disease Zika is an infectious disease transmitted by Aedes mosquitoes, which is also a vector of dengue fever. In Latin America, Zika reached nearly 37,000 infections in 2023, most of which were reported in Brazil. This disease can also be sexually transmitted and can be acquired through blood transfusions. Zika is associated with microcephaly in newborns and in rare cases with the Guillain Barré syndrome. In 2021, 287 cases of microcephaly in children were reported in Brazil, a slight decrease when compared to the number of cases reported in recent years. This health condition disrupts brain growth and can cause intellectual impairment and motor problems. Preventive measures Prevention strategies are essential to reduce the economic and social burden of mosquito-borne diseases such as the Zika virus infection. Preventive measures aim to control and reduce the mosquito population while raising awareness to avoid bites with repellents and the importance of safe sex practices to minimize the risks of infection. Although a vaccine has not yet been approved, it has been estimated that market for the Zika virus vaccine in Latin America could be worth approximately 2.67 billion U.S. dollars by 2024.

Opportunity expenditure, incremental expenditure and annual average cost per household (US$) of Insecticide Treated Curtain implementation in the intervention clusters, Guantanamo, 2009.

We fitted the model to the Culex pipiens complex surveillance data from both traps separately during 2006–2012.Summary of adult female mosquitoes (with mean females per trap night) collected in an EVS trap located at Sams Point neighborhood in Beaufort County, SC from 2006–2012.

In 2023, Brazil reported around 35,000 cases of Zika virus disease, up from around 34,180 infections registered a year earlier. During the period analyzed, 2016 was the year with the most Zika infections in the South American country, with nearly 274,000 cases. In 2024, the value of the Zika virus vaccine market in Latin America is expected to reach approximately 2.7 billion U.S. dollars. Brazil is the most affected country in Latin America The Zika virus disease is mosquito borne and transmitted mainly through the bites of the Aedes aegypti, a mosquito also associated with dengue. Symptoms are often mild and include fever, headache, rashes, and joint pain. However, a Zika infection during pregnancy can cause certain congenital disorders. Between 2021 and 2023, Zika infections nearly doubled in Latin America, with Brazil reporting the highest number of Zika cases, followed by Bolivia and Belize in 2023. As of 2022, the most affected Brazilian region was the Northeast, where the majority of probable Zika cases were recorded. Zika testing market value worldwide As there is still no specific cure, vaccine, or treatment for Zika infections, preventing mosquito bites and safe sexual practices protect against this infection. Moreover, testing for Zika is recommended when symptoms appear after traveling to countries where the disease is still prevalent. Globally, the value of the Zika virus testing market has been increasing since 2020 and is expected to reach over 238 million U.S. dollars by 2026.

*After 24-hour bioassays.Public health insecticides applied from spray trucks to control adult mosquitoes throughout Beaufort County, SC (including the two study sites) during 2006–2012.

Mortality of Cx. erythrothorax exposed to permethrin with or without the synergist PBO (N = 6 BBA per treatment).

Knockdown time and mortality rate of Aedes albopictus populations from southern China using the standard WHO tube susceptibility bioassay against 0.05% deltamethrin.